Cambridge Consultants help with investment decision

Cambridge Consultants has helped Catalent make the final decision on a $20m investment in inhalation drug development and supply facilities.

New Jersey-based Catalent is a global company engaged in drug development and delivery solutions.

The investment, at its Inhalation Center of Excellence in Research Triangle Park, North Carolina, will include the expansion of its pressurized metered dose inhaler clinical and commercial supply capabilities.

Cambridge Consultants was asked by Catalent to validate and challenge its business plans for becoming a contract manufacturer of inhalation products.